TC
AMPH icon

Taika Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Taika Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,775
Closed -$1.78M – 82
2024
Q3 		$1.78M Buy
+36,775
New +$1.61M 1.34% 25

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Taika Capital's AMPH Position: Q4 2024 in Review

Taika Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 36,775 shares — an estimated $1.78M sold.

Taika Capital first reported a position in AMPH in Q3 2024 and held it in 1 quarter. The position peaked at $1.78M in Q3 2024. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Taika Capital reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Taika Capital sold 36,775 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $1.78M.
  • Taika Capital first reported a position in Amphastar Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Taika Capital's Amphastar Pharmaceuticals position peaked at $1.78M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Taika Capital's 13F filing for Q4 2024, filed 7 Feb 2025.